Immunomodulation in Lung Diseases

Series Editors: Marek Lommatzsch and Stephan F. van Eeden

The last 50 years has witnessed major advances in our understanding of the pathophysiology and pathobiology of chronic respiratory diseases. We have also gained deeper insight into the pathogenesis of chronic respiratory conditions and the pivotal role that chronic inflammation plays in disease pathogenesis and disease progression. Immunomodulation in Lung Diseases focuses on four common chronic respiratory conditions (COPD, asthma, interstitial lung disease, and lung cancer), the impact of chronic inflammation and immune dysregulation, and the potential for immunomodulation as a therapeutic option.

• Immune Modulation in Chronic Respiratory Diseases: The Path to Precision Medicine
  Lommatzsch M. · van Eeden S.F.
  Respiration 2020;99:548–549 (DOI:10.1159/000509648)

   

• Immune-Modulation in Chronic Obstructive Pulmonary Disease: Current Concepts and Future Strategies
  van Eeden S.F. · Hogg J.C.
  Respiration 2020;99:550-565 (DOI:10.1159/000502261)

   

• Immune Modulation in Asthma: Current Concepts and Future Strategies
  Lommatzsch M.
  Respiration 2020;99:566-576 (DOI:10.1159/000506651)

   

• Immunomodulation in Autoimmune Interstitial Lung Disease
  Seeliger B. · Prasse A.
  Respiration 2020;99:819-829 (DOI:10.1159/000511200)

   

• Immune Modulation in Lung Cancer: Current Concepts and Future Strategies
  Gaissmaier L. · Christopoulos P.
  Respiration 2020;99:903-929 (DOI:10.1159/000510385)

   

Stay Up-To-Date

Get news according to your interests.

SUBSCRIBE NOW

Contact us

If you have any questions, just get in touch with the Editorial Office